Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014-Reference-Cited by-同舟云学术

Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014

Published:2016-08-23 Issue:10 Volume:63 Page:1288-1294
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Bai Chang-Qing,Mu Jin-Song,Kargbo David,Song Ya-Bin,Niu Wen-Kai,Nie Wei-Min,Kanu Alex,Liu Wei-Wei,Wang Yao-Ping,Dafae Foday,Yan Tao,Hu Yi,Deng Yong-Qiang,Lu Hui-Jun,Yang Fan,Zhang Xiao-Guang,Sun Yang,Cao Yu-Xi,Su Hao-Xiang,Sun Yu,Liu Wen-Sen,Wang Cheng-Yu,Qian Jun,Liu Liu,Wang Hong,Tong Yi-Gang,Liu Ze-Yuan,Chen Yun-Song,Wang Hong-Quan,Kargbo Brima,Gao George F.,Jiang Jia-Fu

Funder

National Science Foundation of China

National Science and Technology Major

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/63/10/1288/7937479/ciw571.pdf

Reference27 articles.

1. Emergence of Zaire Ebola Virus Disease in Guinea

2. World Health Organization. Ebola situation report—6 January 2016. Available at: http://apps.who.int/ebola/sites/default/files/atoms/files//who_ebola_situation_report_06-01-2016.pdf2016. Accessed 30 January 2016.

3. The International Ebola Emergency

4. Illness due the Ebola virus: epidemiology and clinical manifestations within the context of an international public health emergency;Carod-Artal;Rev Neurol,2015

5. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Metastable Zone Widths: Optimizing the Nucleation Potential Model with Solid–Liquid Interfacial Energy;Industrial & Engineering Chemistry Research;2024-02-28

2. Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID);Pneumonia;2024-02-25

3. Favipiravir for treating COVID-19;Cochrane Database of Systematic Reviews;2024-02-05

4. Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure–Property Relationship, and Molecular Docking Study;Molecules;2024-01-16

5. The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey;The Journal of Infection in Developing Countries;2023-11-30